The measurement of immune responses in partially and fully vaccinated individuals is desirable for comparing vaccination regimens, evaluating immunocompromised individuals, monitoring responses to ...
The World Health Organization (WHO) has reported over 361 million confirmed coronavirus disease 2019 (COVID-19) cases, of which include over 5.62 million deaths as of January 2022. Several vaccines ...
The advent of new and precise high-throughput screening technologies has opened up a vast resource for understanding the molecular mechanisms underlying disease, genetic disorders, and immune ...
First-in-human phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide (LNA-ASO) to androgen receptor (AR) mRNA in patients with castration-resistant prostate cancer (CRPC). CD54 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results